The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma

Haematologica. 2015 Feb;100(2):e53-5. doi: 10.3324/haematol.2014.115162. Epub 2014 Nov 7.
No abstract available

Keywords: MRD; flow cytometry; myeloma; relapse.

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Combined Modality Therapy
  • Flow Cytometry / methods*
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Multiple Myeloma / mortality
  • Multiple Myeloma / pathology*
  • Multiple Myeloma / therapy
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Recurrence, Local / pathology*
  • Neoplasm Recurrence, Local / therapy
  • Neoplasm Staging
  • Neoplasm, Residual / mortality
  • Neoplasm, Residual / pathology*
  • Neoplasm, Residual / therapy
  • Prognosis
  • Survival Rate
  • Transplantation, Autologous